Clinical Trial: Cognitive-Behavioral Therapy for Pediatric Body Dysmorphic Disorder

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: An Open Trial of Cognitive-Behavioral Therapy (CBT) for Pediatric Body Dysmorphic Disorder (BDD)

Brief Summary: The purpose of this study is to develop and test the effectiveness of Cognitive-Behavioral Therapy (CBT) for children and adolescents suffering from Body Dysmorphic Disorder.

Detailed Summary:

The main purpose of this trial is to develop and investigate the effects of a CBT protocol for children and adolescents with BDD. It is important to investigate CBT in this population given the disorder's early onset and poor trajectory if left untreated.

In the first phase of this trial, we will develop the treatment manual, adapting the adult manual for use in a pediatric population. In the second phase of this trial we will test the effectiveness of the CBT treatment in 12 pediatric BDD patients. We intend to treat 12 children and adolescents with BDD. All patients will receive CBT. We will also examine treatment feasibility and acceptability (e.g., retention and reasons for treatment refusal and dropout, expectancy, and motivation), and we will explore predictors of outcome. Therapeutic progress will be broadly assessed with measures of beliefs, behaviors, mood, functioning, and quality of life before, during, and after treatment.


Sponsor: Massachusetts General Hospital

Current Primary Outcome: Yale-Brown Obsessive Compulsive Scale Modified for BDD (BDD-YBOCS)-Pediatric Version [ Time Frame: Baseline, Monthly, Post-Treatment, 3-Month Follow-Up, 6-Month Follow-Up ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

  • Brown Assessment of Beliefs Scale (BABS)-Pediatric Version [ Time Frame: Baseline, Monthly, Post-Treatment, 3-Month Follow-Up, 6-Month Follow-Up ]
  • Clinical Global Impression Scale (CGI) [ Time Frame: Baseline, Monthly, Post-Treatment, 3-Month Follow-Up, 6-Month Follow-Up ]
  • Children's Depression Inventory (CDI) [ Time Frame: Baseline, Weekly, Post-Treatment, 3-Month Follow-Up, 6-Month Follow-Up ]


Original Secondary Outcome: Same as current

Information By: Massachusetts General Hospital

Dates:
Date Received: October 26, 2009
Date Started: June 2009
Date Completion:
Last Updated: March 15, 2016
Last Verified: March 2016